RSS Feeds
Status of Immunity to Tetanus, Measles, Mumps, Rubella, and Polio among U.S. Travelers
- Eileen Hilton, MD;
- Carol Singer, MD;
- Phyllis Kozarsky, MD;
- Miriam A. Smith, MD;
- M. Peter Lardis, BA; and
- Michael T. Borenstein, PhD
Excerpt
Visitors to developing countries should be counseled and vaccinated on the basis of data about the prevalence of diseases in the areas to be visited, the traveler's level of immunity, the type of travel, and the length of stay. Little is known about the antibody status of U.S. travelers. To assess their vulnerability, we conducted a serologic survey.
Methods From July through September 1988, travelers attending the Long Island Jewish Medical Center Travel & Immunization Center (New Hyde Park, New York) and the Travel Well Center at Crawford M. Long Hospital (Atlanta, Georgia) were asked to participate in a pretravel
Acknowledgments
Acknowledgments: The authors thank the Centers for Disease Control Division of Immunization; Lauri Markowitz, MD, and Adamadia Deforest, PhD, of St. Christopher's Hospital for Children in Philadelphia, for their assistance in antibody testing; and Carol Bertsch for secretarial help.
Article and Author Information
-
From the Long Island Jewish Medical Center, New Hyde Park, New York; and Emory University School of Medicine, Atlanta, Georgia. For current author addresses, see end of text.
-
Requests for Reprints: Eileen Hilton, MD, Long Island Jewish Medical Center, Lakeville Road, Room B-202, New Hyde Park, NY 11042.
-
Current Author Addresses: Drs. Hilton, Singer, Smith, and Borenstein and Mr. Lardis: Long Island Jewish Medical Center, Lakeville Road, Room B-202, New Hyde Park, NY 11042.
Dr. Kozarsky: Emory University School of Medicine, 20 Linden Avenue, Suite 101G, Atlanta, GA 30365.
